Overview
A prospective feasibility study would be a practical first step, focusing on real-time assessment and ensuring the new working element's integration is safe and effective before broader clinical trials.
Eligibility
Inclusion Criteria:
- Diagnosed with benign prostatic hyperplasia (BPH) requiring surgical intervention.
- Prostate volume ≥40 cc (as assessed by transrectal ultrasound).
- No prior history of prostate cancer.
Exclusion Criteria:
- Patients with ongoing urinary tract infections.
- Prior prostate surgeries.
- Coagulation disorders or patients on long-term anticoagulation therapy.
- Known urethral strictures or other anatomical abnormalities complicating endoscopic procedures.